| Full Name | David Lopez |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 301 Broadway, Chelsea, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003342312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Lopez, 301 Broadway, Chelsea, MA 02150-2807 Ph: (617) 912-7914 | David Lopez, 301 Broadway, Chelsea, MA 02150-2807 Ph: (617) 912-7914 |
News Archive
Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.
The bipartisan treatment the FDA user fee bill has enjoyed did not fall like manna from heaven. It came at the insistence of the pharmaceutical and medical device industries, the FDA and legislators on both sides of the aisle who agreed early on they would get a deal done. And then actually did it.
For decades, hormone replacement therapy (HRT) was prescribed for postmenopausal women to protect them from cardiovascular disease (CVD). However, results from the Women's Health Initiative questioned its effectiveness, which has led to more caution in prescribing and using HRT for this purpose.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
› Verified 1 days ago
Elizabeth Cabrera, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7912 | |
Mr. Manuel De Pena, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-972-7914 | |
Karen Alejandra Salazar, Counselor Medicare: Not Enrolled in Medicare Practice Location: 70 Everett Ave Ste 515, Chelsea, MA 02150 Phone: 617-466-6650 | |
Mistere Ayele, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7914 | |
Kayla Nicole Lyons, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-488-5735 Fax: 617-912-7971 | |
Lesette Wright, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7914 |